Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple camera replace fancy Motion-Capture suits?

NCT ID NCT06544824

Knowledge-focused Sponsor: IRCCS Eugenio Medea Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a markerless motion analysis system (OpenPose) can accurately measure walking patterns compared to a standard optoelectronic system that uses markers. Researchers recorded 25 people (ages 4 and up) with various motor impairments while they walked. The goal was to see if the simpler, cheaper camera-based method could reliably track movement and gait parameters.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

25 people

The number who actually took part.

Started

May 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study includes subjects who previously underwent a functional motor assessment using the SMART DX 100 system at the IRCCS Eugenio Medea Institute. The sample comprises both healthy individuals and those with walking difficulties, all aged over 4 years.

Ages

4 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age over 4 years; * Ability to walk independently without walking aids and/or orthoses. Exclusion Criteria: * Inability to walk independently and safely for short distances without walking aids and/or orthoses.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Children, adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Disorders movement disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Children, adult Motor disorders

Contacts and locations

Locations

  • IRCCS E. Medea

    Bosisio Parini, Italy, 22037, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.